List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 929 studies with search of:   Australia, Victoria
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Active, not recruiting Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate
22 Recruiting Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
23 Completed Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Condition: Chronic Hepatitis C
Interventions: Drug: albumin interferon alfa-2b;   Drug: peginterferon alfa-2a;   Drug: Ribavirin
24 Recruiting Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: adjuvant therapy;   Procedure: oophorectomy;   Procedure: radiation therapy
25 Recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Deep-Vein Thrombosis (DVT) Without Symptomatic Pulmonary Embolism: Einstein-DVT Evaluation
Condition: Deep Vein Thrombosis
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin followed by VKE
26 Completed Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage
Conditions: CVA (Cerebrovascular Accident);   Cerebral Hemorrhage;   Intracranial Hemorrhages
Interventions: Drug: Labetalol Hydrochloride;   Drug: Metoprolol tartrate;   Drug: Hydralazine Hydrochloride;   Drug: Glycerol Trinitrate;   Drug: Phentolamine mesylate;   Drug: Nicardipine;   Drug: Urapidil;   Drug: Esmolol;   Drug: Clonidine;   Drug: Enalaprilat;   Drug: Nitroprusside
27 Completed RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery
Conditions: Arthroplasty, Replacement, Knee;   Thromboembolism
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
28 Active, not recruiting Study to Assess the Safety of CDP870 for up to 30 Months Following Reintroduction of Treatment
Condition: Crohn's Disease
Intervention: Biological: CDP870
29 Active, not recruiting A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CCX282-B
30 Completed Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Salmeterol 50mcg/ Fluticasone Propionate 500mcg
31 Active, not recruiting A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: epirubicin;   Drug: cisplatin;   Drug: 5-fluorouracil;   Radiation: Radiotherapy
32 Completed Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
Conditions: Thromboembolism;   Arthroplasty, Replacement, Hip
Interventions: Drug: "Dabigatran etexilate (oral, 150 mg once daily)";   Drug: "Enoxaparin (subcutaneous, 40 mg once daily)";   Drug: "Dabigatran etexilate (oral, 220 mg once daily)"
33 Completed Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
Condition: Acute Myocardial Infarction
Interventions: Drug: Pexelizumab;   Drug: Placebo infusion
34 Active, not recruiting Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)
Condition: Stroke
Intervention: Drug: Alteplase t-PA
35 Active, not recruiting Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients
Condition: Leukemia, Myeloid, Chronic Phase
Intervention: Drug: Imatinib mesylate
36 Recruiting Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
Condition: Breast Cancer
Intervention: Drug: Alendronate sodium
37 Completed BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin;   Drug: Warfarin;   Drug: Enoxaparin Placebo;   Drug: Apixaban Placebo
38 Completed Efficacy Study of Outpatient Therapy for Lymphoma
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Intervention: Drug: gemcitabine, vinorelbine, ifosfamide
39 Terminated A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
Conditions: Coronary Disease;   Diabetes Mellitus
Interventions: Drug: torcetrapib/atorvastatin;   Drug: atorvastatin
40 Recruiting Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Condition: Advanced Renal Cell Carcinoma
Intervention: Drug: pazopanib

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services